08.03.2014 Views

14th ICID - Poster Abstracts - International Society for Infectious ...

14th ICID - Poster Abstracts - International Society for Infectious ...

14th ICID - Poster Abstracts - International Society for Infectious ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

When citing these abstracts please use the following reference:<br />

Author(s) of abstract. Title of abstract [abstract]. Int J Infect Dis 2010;14S1: Abstract number.<br />

Please note that the official publication of the <strong>International</strong> Journal of <strong>Infectious</strong> Diseases 2010, Volume 14, Supplement 1<br />

is available electronically on http://www.sciencedirect.com<br />

Final Abstract Number: 30.010<br />

Session: Mycology, Fungal Infections and Antifungal Drugs<br />

Date: Wednesday, March 10, 2010<br />

Time: 12:30-13:30<br />

Room: <strong>Poster</strong> & Exhibition Area/Ground Level<br />

Type: <strong>Poster</strong> Presentation<br />

Recurrent/resistant fungal infections in females<br />

N. Como 1 , D. Kraja 2 , N. Gjermeni 3 , M. Qato 3 , A. Kica 3 , K. Duraku 3<br />

1 University Hospital Centre "Mother Theresa", Tirana, AL, Albania, 2 Faculty of Medicine, Tirane,<br />

Albania, 3 HUC, Tirane, Albania<br />

Background: Recognition of epidemiological,etiological,topographical and treatment aspects. In this study are included 45 cases,18-35 years-old,<br />

during the years 1999–2008 with recurrent (at least 4 episodes of fungal infections in a year)/resistant (which doesn’t respond to antifungal therapy)<br />

fungal infections.<br />

Methods: We have analyzed the group-ages,the origin and the immunity state of the patients.We have determined the etiology,topographic variant<br />

of the fungal infections and the real sensibility against antifungal drugs (Ketoconazol, Intraconazol,Fluconazol,Clotrimazol).<br />

Results: Epidemiologic:<br />

Group-ages Number of cases<br />

18-21 1<br />

22-25 8<br />

26-30 11<br />

31-35 25<br />

Where 28 were citizien, and 17 were peasants.<br />

The immune state:<br />

a)immunocompetent-30 cases<br />

b)immune-compromised-15 cases<br />

Diagnosis<br />

Number of cases<br />

HIV 4<br />

colagenosis 4<br />

Diabetes Mellitus 2<br />

Lymphoma 1<br />

Visceral Leishmania 1<br />

Hypogamaglobulinemi 1<br />

Thyrotoxicosis 1<br />

Chronic hepatitis 1<br />

Disease-topographic:Oro-pharyngeal fungal infection-42 cases<br />

Topography<br />

Number of cases<br />

keilitis 6<br />

glositis 9<br />

pharyngitis 5<br />

pharynx–esophagitis 4<br />

Disease-topographic:dermal-16<br />

Topography Number of cases<br />

axillary 1<br />

submamare 2<br />

inguinal 3<br />

gluteal 3<br />

intradigital 4<br />

Disease-topographic:vulvovaginale -26<br />

Topography Number of cases<br />

anal-perianal 2<br />

onicomycosis 2<br />

Etiologic:Candida albicans -33 cases<br />

Candida glabriatra -5 cases<br />

Trichophyton-6 cases<br />

Criptoccocus Laurens-1 case.<br />

Therapeutic:According to mycogram,the clinical response and the subject quality.<br />

-In (19) resistant cases we have:<br />

a)repeated the therapeutic cycle(in 11 cases)<br />

b)extended the local treatment(10 cases),<br />

c)associated the systemic treatment(16 cases),<br />

d)changed the antifungal drugs(13 cases).<br />

We have done diagnose reconfirmation(2 cases from 8 has resulted misdiagnosed).<br />

3 from 5 cases with candida glabriata were resistand against azole.<br />

-In (26) recurrent cases we have applied the treatment with (Fluconazol 100 mg(p.o)or supp.Cotrimazol 500 mg 1 time/week until 6 month)<br />

In 14 cases, after the treatment of recurrent episodes(fluconazol 100–200mg/day/7–14 days) we have improved the management of immunecompromised<br />

disease of subjects in 13 cases.<br />

Conclusion: The recurrent/resistant fungal infections are encountered more frequently in group-ages 31-35 years-old,54% of all cases.<br />

33% were immune-compromised;<br />

67% were immune-competent (women).<br />

6% of all cases were named as idiopathic,the long-term treatment resulted ineffective.<br />

Vulvo-vaginal fungal infections were predominated in 57.7% of cases.<br />

The most frequent etiologic cause was Candida albicans(73.3%).<br />

The resistant fungal infections were 42.2% of all cases; recurrent 57.7%.<br />

The treatment in the resistant <strong>for</strong>ms has resulted effective in 84.2% and ineffective in 15.7%;in the recurrent <strong>for</strong>ms 73.1% effective and 26.9% ineffective.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!